Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

NanoViricides Inc. (NNVC)

Add NNVC Price Alert      Hide Sticky   Hide Intro
Moderator: I AM BETTER THAN YOU, LilBigKahuna, Steady_T, NewMoney, drkazmd65
Search This Board: 
Last Post: 6/24/2017 5:19:01 PM - Followers: 464 - Board type: Free - Posts Today: 7

NanoViricides, Inc (NNVC)

Company Address:
135 Wood St, Suite 200
West Haven, CT 06516
Phone:  203-937-6137
Fax:  203-859-5095
CIK:  0001379006
NanoViricides, Inc. is a development stage company with a unique nanomedicine technology. The Company is developing nanotechnology-based biomimetic anti-viral medicines, that we call "nanoviricides®". 
A "nanoviricide" is an antiviral agent designed by the Company to fool a virus into attaching to this agent in the same way that the virus normally attaches to receptors on a cell surface. Once attached, the flexible nanoviricide glob would wrap around the virus and trap it. In the process, the virus could lose its coat proteins that it needs to bind to a cell. The virus is thus neutralized and effectively destroyed. Nanoviricides are designed to complete the task of dismantling the virus particle without immune system assistance.
Thus nanoviricides represent the next great advance in "Immunotherapeutics" (antibodies and vaccines,) the well established antiviral strategies. Viruses have developed smart strategies to derail immune system function. This results in failure of antibodies and vaccines.
The nanoviricide technology attempts to circumvent virus escape that results from natural changes in virus structure. Despite all such changes, the cell receptor to which a virus binds remains the same. Nanoviricides mimic this conserved feature of virus binding to its host cell receptor. If a virus "escapes" a properly designed nanoviricide, it would have a reduced ability to attach to the cell receptor and would have become much less pathogenic in the process.
Recent News:

Micrographic images of nanoviricide micelles in action against Murine Cytomegalovirus:

SEC Filings:
Share Structure:  See SEC filings for current share structure
Investor Relations:
Amanda Schuon, 310-550-7200


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NNVC News: NanoViricides Abstract Accepted for Poster Presentation at the 2017 Annual Meeting of American Society of Virology 06/20/2017 07:00:00 AM
NNVC News: NanoViricides CEO to Present Information on Its Topical Shingles Treatment At the 2017 Marcum Investor Conference in New York... 06/13/2017 07:00:00 AM
NNVC News: NanoViricides Reports Excellent Inhibitory Effects of Its Topical Shingles Treatment Candidates Against VZV in Multiple Cell ... 06/06/2017 05:30:00 PM
NNVC News: NanoViricides Files Quarterly Report for Period Ending 2017-03-31 05/16/2017 07:50:00 AM
NNVC News: Quarterly Report (10-q) 05/15/2017 05:03:04 PM
#133285  Sticky Note Cash is of no concern whatsoever to nnvc Ubertino 06/08/17 01:44:18 PM
#128296  Sticky Note When someone claims to have cured the "near arvitar 12/26/16 02:27:41 PM
#126117  Sticky Note A solid step forward: NanoViricides Signs Agreement drkazmd65 10/31/16 07:46:04 AM
#120585  Sticky Note Well Said! MJJONES 04/28/16 08:35:40 PM
#133621   Fraudsters are trying their best to kill it though. Stockbuilder 06/24/17 05:19:01 PM
#133620   The inability to manufacture is the perfect way Nanotoday 06/24/17 04:56:29 PM
#133619   Still No TOX after 13 years !? However, TheBunny 06/24/17 03:03:19 PM
#133618   And when NNVC can't manufacture Shinglescide in sufficient JG36 06/24/17 01:34:50 PM
#133617   We are 2+ years from when NNVC decided Nanotoday 06/24/17 03:45:23 AM
#133616   True. They are reaping a bumper crop. Steady_T 06/24/17 01:38:37 AM
#133615   Fruit? Ha! What has come to fruition with NewMoney 06/24/17 12:20:57 AM
#133614   Doom? Ha! Just a delay while they went drkazmd65 06/23/17 09:53:52 PM
#133613   I think you're right on all counts here. JG36 06/23/17 06:48:56 PM
#133612   Correct. And toxicity testing is where Flucide JG36 06/23/17 06:40:10 PM
#133611   Well, NNVC didn't close at 1.45. But JG36 06/23/17 06:37:14 PM
#133610   No need for FDA's hoops. leifsmith 06/23/17 03:25:02 PM
#133609   We know that the insiders continue to get TheBunny 06/23/17 03:02:10 PM
#133608   I would not want to base an investment JG36 06/23/17 02:53:24 PM
#133607   I never said NNVC is about to go JG36 06/23/17 02:51:20 PM
#133606   Tox can not be completed until they can Nanotoday 06/23/17 01:37:28 PM
#133605   They claimed to have had a gov't contract Nanotoday 06/23/17 12:58:13 PM
#133604   They haven't achieve 200g scale up yet. Nanotoday 06/23/17 12:54:39 PM
#133603   In 2013, the company claimed to have nine arvitar 06/23/17 12:50:44 PM
#133602   Agreed Ubertino! drkazmd65 06/23/17 12:47:00 PM
#133601   NNVC is a roaring success!! Ubertino 06/23/17 12:44:12 PM
#133600   I recall Moffat found no toxicity whatsoever of Ubertino 06/23/17 12:43:22 PM
#133599   With such a geriatric view of history and Magnus1 06/23/17 12:41:23 PM
#133598   Toxicity testing is the 'next step' once Moffat's drkazmd65 06/23/17 12:39:23 PM
#133597   FDA next. Ubertino 06/23/17 12:31:30 PM
#133596   Suppose Moffat manages to finish repeating her skin arvitar 06/23/17 12:23:29 PM
#133595   Don't know!! Ubertino 06/23/17 12:22:44 PM
#133594   They are giving it their very best shot! Ubertino 06/23/17 12:17:58 PM
#133593   Yep it was. Discovered in 1928 and wasn't Steady_T 06/23/17 11:32:31 AM
#133592   The Company has an accumulated deficit at March arvitar 06/23/17 11:25:54 AM
#133591   Progress indeed! Ubertino 06/23/17 11:19:02 AM
#133590   Four years ago it was: arvitar 06/23/17 11:07:26 AM
#133589   But surely the BP with a licensing deal Ubertino 06/23/17 10:39:10 AM
#133588   Certainly looks promising! Ubertino 06/23/17 10:32:35 AM
#133587   Agreed - Personally I view this as the drkazmd65 06/23/17 10:14:58 AM
#133586   I don't think they have officially stated that leifsmith 06/23/17 10:07:28 AM
#133585   Every single large pharma has expressed an interest arvitar 06/23/17 09:53:06 AM
#133584   Moffat results prove unequivocally that NanoViricides is a Ubertino 06/23/17 09:36:41 AM
#133582   Pop goes the weasel! Ubertino 06/23/17 09:28:27 AM
#133581   Well worth the investment! Ubertino 06/23/17 09:27:27 AM
#133580   We should be so lucky....and so gifted! Ubertino 06/23/17 09:25:38 AM
#133579   Yes, still ... always so leifsmith 06/23/17 09:03:46 AM
#133578   I've only seen thinly traded microcaps like NNVC, arvitar 06/23/17 07:18:09 AM
#133577   He got a bonus! ROFL , LOLOL. That's NewMoney 06/23/17 03:33:27 AM
#133576   That is true. Edison & Co tried 6000 Steady_T 06/22/17 11:25:47 PM
#133575   The amount of time spent attempting to solve leifsmith 06/22/17 11:13:08 PM
#133574   Yeah..... That's a thin reed. Ummmm Steady_T 06/22/17 11:06:31 PM
#133573   Another faulty assumption, posted as a desperate response leifsmith 06/22/17 10:33:36 PM
#133572   The assumption that NNVC is "about to go drkazmd65 06/22/17 10:13:38 PM
#133571   I would love to hear the NNVC board JG36 06/22/17 09:33:42 PM